Ben Kallo’s rating is based on a combination of factors, including Lucid Group’s recent financial performance and strategic developments. The company’s Q3 results were largely in line with ...

Link Parks Inc. Dep. Pfd. (Rep. 1/1000th 5.25% Cum. Redeem. Pfd. Series X) 0.37% Link Parks Inc. Dep. Pfd. (Rep. 1/1000th Share 4.875% Pfd. Series Z) 0.37% Link Parks ...

Innovative Industrial Properties Inc. 9% Cum. Conv. Redeem. Pfd. Series A 0.69% Digital Realty Trust Inc. 5.25% Cum. Conv. Pfd. Series J-0.17% Digital Realty Trust Inc. 5.2% Cum. Redeem.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In Novartis’ favour is that there are plenty of other companies working on IgAN therapies, including Ionis/Roche’s antisense-based complement factor B therapy IONIS-FB-LRx, Omeros’ anti-MASP ...